close

Mergers and Acquisitions

1 2 3 35
Number of results: 681
Date Acquired company Acquiring company Amount Related
2019-08-13 Synpromics (UK) Asklepios BioPharmaceutical (AskBio) (USA - NC) undisclosed Gene Therapy - Rare diseases
2019-07-23 3P Pharmaceuticals (Spain) Keensight Capital (France) undisclosed
2019-07-15 Amal Therapeutics (Switzerland) Boehringer Ingelheim (Germany) up to € 425 million Cancer - Oncology
2019-06-19 PuREC (Japan) Fujifilm (Japan) ¥ 300 million CDMO
2019-05-20 Paragon Bioservices (USA - MD) Catalent (US - NJ) $1.2 billion CMO - CDMO - Gene therapy
2019-05-20 Aegerion Pharmaceuticals, a Novelion Therapeutics subsidiary (Canada) Amryt Pharma (UK) Rare diseases
2019-05-01 Brammer Bio (USA - MA) Thermo Fisher Scientific (USA - MA) $1.7 billion Technology - Services
2019-04-04 Apceth Biopharma (Germany) Hitachi Chemical (Japan) €75.5 million Technologies - Services - Bioproduction
2019-04-01  IFM Tre, a subsidiary of IFM Therapeutics (USA - MA) Novartis (Switzerland) CNS diseases - Inflammatory diseases - Fibrotic diseases - Liver diseases
2019-03-20 15% equity interest in Vivet Therapeutics (France) Pfizer (USA - NY) €45 million (US$51 million) Rare Diseases - Metabolic Diseases
2019-03-11 Asterias Biotherapeutics (USA - CA) Biotime (USA - CA) undisclosed cell therapy
2019-03-08 Stellar Biotechnologies (USA - CA) Edesa Biotech (Canada)
  • Dermatological diseases - Gastrointestinal diseases
2019-03-04 NightstaR Therapeutics (UK) Biogen (USA - MA) $800 million Ophtalmological diseases - Gene therapy
2019-02-25 Spark Therapeutics (USA - PA) Roche (Switzerland) $ 4.3 billion Rare diseases - Genetic diseases - Hematological diseases - Ophtalmological diseases
2019-02-25 Clementia Pharmaceuticals (Canada) Ipsen (France) $1.31 billion Rare diseases - Bone diseases - Ophtalmological diseases
2019-02-22 Celgene (USA - NJ) BMS (USA - NY) $74 billion Cancer - Oncology - Cardiovascular diseases - Immunological diseases - Inflammatory diseases
2019-02-13 Citoxlab (France) Charles River Laboratories (USA - MA) €448 million Technology - Services
2019-01-25 Apricus Therapeutics (USA - CA) Seelos Therapeutics (USA - NY) CNS diseases - Rheumatic diseases
2019-01-25 Capua BioServices (Italy)) Olon (Italy)) CDMO - Technology - Services
2019-01-23 MAB Discovery's antibody generation unit (Germany) BioNTech (Germany) undisclosed Technologies - Services